chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Photosensitivity reaction
Clinical narrative: Photosensitivity resulting in anxiety after exposure to bright lights; Photosensitivity resulting in anxiety after exposure to bright lights; This is a spontaneous report from a contactable nurse. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the left arm on 25Aug2021 at 15:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to citrus. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 28Jul2021 at 14:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 01Sep2021 at 14:00, the patient experienced photosensitivity resulting in anxiety after exposure to bright lights. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events photosensitivity resulting in anxiety after exposure to bright lights was unknown at the time of the report.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Laryngitis
Clinical narrative: Hoarse voice; Laryngitis; This is a spontaneous report from a contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Sep2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 04Sep2021 at 12:00, the patient experienced hoarse voice and laryngitis. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hoarse voice and laryngitis were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Paraesthesia, Peripheral coldness
Clinical narrative: Cold feet; Tingling in legs and thighs; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the right arm on 30Aug2021 at 10:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 01Sep2021, the patient experienced cold feet, tingling in legs and thighs and weakness. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events cold feet, tingling in legs and thighs and weakness were resolving at the time of report.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Ear pain, Fatigue, Headache
Clinical narrative: Frequent urination; Ear ache; Incapacitated; Sore throat; Weakness; Swelling of the face and throat; Swelling of the face and throat; Exhaustion; Headache; Muscle pain; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Sep2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Aug2021 at 16:00 as a single dose for COVID-19 immunisation. On 03Sep2021 at 14:00, the patient experienced swelling of the face and throat, weakness, exhaustion, head ache, muscle pain, chills, fever, sore throat, ear ache, frequent urination and incapacitated. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swelling of face and throat, weakness, exhaustion, headache, muscle pain, chills, fever, sore throat, ear ache, frequency urination and incapacitated were resolving at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Myalgia, Oropharyngeal pain, Pharyngeal swelling, Pollakiuria
Clinical narrative: Frequent urination; Ear ache; Incapacitated; Sore throat; Weakness; Swelling of the face and throat; Swelling of the face and throat; Exhaustion; Headache; Muscle pain; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Sep2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Aug2021 at 16:00 as a single dose for COVID-19 immunisation. On 03Sep2021 at 14:00, the patient experienced swelling of the face and throat, weakness, exhaustion, head ache, muscle pain, chills, fever, sore throat, ear ache, frequent urination and incapacitated. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swelling of face and throat, weakness, exhaustion, headache, muscle pain, chills, fever, sore throat, ear ache, frequency urination and incapacitated were resolving at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face
Clinical narrative: Frequent urination; Ear ache; Incapacitated; Sore throat; Weakness; Swelling of the face and throat; Swelling of the face and throat; Exhaustion; Headache; Muscle pain; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Sep2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Aug2021 at 16:00 as a single dose for COVID-19 immunisation. On 03Sep2021 at 14:00, the patient experienced swelling of the face and throat, weakness, exhaustion, head ache, muscle pain, chills, fever, sore throat, ear ache, frequent urination and incapacitated. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swelling of face and throat, weakness, exhaustion, headache, muscle pain, chills, fever, sore throat, ear ache, frequency urination and incapacitated were resolving at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysmenorrhoea, Headache, Menstruation delayed, Menstruation irregular
Clinical narrative: missed periods; Period cramps for a week now; Period still hasnt came; Nauseous A few days; Chills; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Aug2021 at 12:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On an unknown date in 2021, the patient experienced missed period, period cramps for a week (at the time of reporting), nauseous a few days, chills and mild headache, periods still did not come. The patient also reported that she was not pregnant. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events missed period, period cramps, nauseous, chills and mild headache, periods did not come was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: missed periods; Period cramps for a week now; Period still hasnt came; Nauseous A few days; Chills; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Aug2021 at 12:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On an unknown date in 2021, the patient experienced missed period, period cramps for a week (at the time of reporting), nauseous a few days, chills and mild headache, periods still did not come. The patient also reported that she was not pregnant. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events missed period, period cramps, nauseous, chills and mild headache, periods did not come was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Paraesthesia
Clinical narrative: Tingling in extremities 7 weeks after 2nd dose which persists/is worsening after 10 days; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Jun2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was notdiagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient had tingling in extremities on 23Aug2021, 7 weeks after the second dose, which had persisted and worsened after 10 days. The patient visited a neurologist which resulted in magnetic resonance imaging (MRI) and electromyography (EMG) was ordered to be done as soon as possible. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tingling in extremities 7 weeks after 2nd dose which persists/is worsening after 10 days was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow-up.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Product administered at inappropriate site
Clinical narrative: Baseball size swollen node under right armpit formed; Baseball size swollen node under right armpit formed very painful; Administration site left leg; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left leg on 27Aug2021 at 09:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, polycystic ovarian syndrome (PCOS), sleep apnea and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Aug2021 at 16:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 27Aug2021 at 12:00, within 3 hours of vaccination, the patient experienced a baseball size swollen node under right armpit formed which was very painful for 3 days and it had lasted 6 days total. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events baseball size swollen node under right armpit formed very painful was resolved on 02Sep2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Eye pruritus, Feeling hot, Headache
Clinical narrative: Light headed; Very hot; Chills; Headache; Itchy eyes; Itchy skin; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 12:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 02Sep2021 at 12:45, the patient experienced light headed, very hot, chills, headache, itchy eyes and itchy skin. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of light headed, very hot, chills, headache, itchy eyes and itchy skin were unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Light headed; Very hot; Chills; Headache; Itchy eyes; Itchy skin; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 12:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 02Sep2021 at 12:45, the patient experienced light headed, very hot, chills, headache, itchy eyes and itchy skin. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of light headed, very hot, chills, headache, itchy eyes and itchy skin were unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, SARS-CoV-2 test
Clinical narrative: Congestion; Cough ongoing; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Aug2021 at 08:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 23Aug2021 at 10:30, the patient experienced congestion and cough ongoing. The events resulted in doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 01Sep2021, the patient underwent COVID test via nasal swab and the result was negative. Therapeutic measures were taken as a result of events which included treatment with unspecified antibiotic for bacterial infection. The clinical outcome of the events congestion and cough ongoing were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Headache, Pain in extremity, Peripheral swelling, Rash
Clinical narrative: Full body rash two days later; Headache and metallic taste on tongue within the hour.; Metallic taste on tongue within the hour.; Left arm swollen and soreness through the next two days.; Left arm swollen and soreness through the next two days.; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 30Aug2021 at 15:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 30Aug2021, the patient experienced headache and metallic taste on tongue within the hour, left arm swollen and soreness through the next two days. On 01Sep2021, the patient experienced full body rash two days later. The clinical outcome of the events headache and metallic taste on tongue within the hour, left arm swollen and soreness, full body rash was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia, Vaccination site erythema
Clinical narrative: Fever that lasted 36 hours, peaked at 100.9; Chills; Extreme fatigue; Injection site pain; Injection site pain, redness; Injection site pain, redness & swelling; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: FF2588Wag5760) via an unspecified route of administration in the left arm on 30Aug2021(at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing.  On 31Aug2021, the patient experienced fever that lasted 36 hours, peaked at 100.9, chills, extreme fatigue, injection site pain, redness and swelling. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event fever was recovered on an unknown date in Sep2021, while that of chills, extreme fatigue, injection site pain, redness and swelling was recovering at the time of this report.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Fever that lasted 36 hours, peaked at 100.9; Chills; Extreme fatigue; Injection site pain; Injection site pain, redness; Injection site pain, redness & swelling; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: FF2588Wag5760) via an unspecified route of administration in the left arm on 30Aug2021(at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing.  On 31Aug2021, the patient experienced fever that lasted 36 hours, peaked at 100.9, chills, extreme fatigue, injection site pain, redness and swelling. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event fever was recovered on an unknown date in Sep2021, while that of chills, extreme fatigue, injection site pain, redness and swelling was recovering at the time of this report.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Migraine, Musculoskeletal stiffness, Nausea
Clinical narrative: Had an ongoing migraine with nausea; Had an ongoing migraine with nausea; Stiff neck pain; Stiff neck pain; Overall body fatigue; Cough; Fever; Right arm where injection site is feels like someone punch the crap out of, cannot lay on the right side when sleeping; This is a spontaneous report from a contactable healthcare professional, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the right arm on 31Aug2021 at 09:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication was not reported. The patient had no known drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Aug2021 at 11:00, since the patient got the first dose and had an ongoing migraine with nausea, stiff neck pain, overall body fatigue, cough, and fever. Her right arm where injection site was felt like someone punched the crap out of her, the patient could not lay on the right side when sleeping. Since the vaccination, the patient had not been tested for COVID-19. The therapeutic measures were not taken as a result of the events. The clinical outcome of the events had an ongoing migraine with nausea, stiff neck pain, overall body fatigue, cough, and fever; her right arm where injection site was felt like someone punched the crap out of her, the patient could not lay on the right side when sleeping was not resolved at the time of this report.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia, Vaccination site pain
Clinical narrative: Had an ongoing migraine with nausea; Had an ongoing migraine with nausea; Stiff neck pain; Stiff neck pain; Overall body fatigue; Cough; Fever; Right arm where injection site is feels like someone punch the crap out of, cannot lay on the right side when sleeping; This is a spontaneous report from a contactable healthcare professional, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the right arm on 31Aug2021 at 09:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication was not reported. The patient had no known drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Aug2021 at 11:00, since the patient got the first dose and had an ongoing migraine with nausea, stiff neck pain, overall body fatigue, cough, and fever. Her right arm where injection site was felt like someone punched the crap out of her, the patient could not lay on the right side when sleeping. Since the vaccination, the patient had not been tested for COVID-19. The therapeutic measures were not taken as a result of the events. The clinical outcome of the events had an ongoing migraine with nausea, stiff neck pain, overall body fatigue, cough, and fever; her right arm where injection site was felt like someone punched the crap out of her, the patient could not lay on the right side when sleeping was not resolved at the time of this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, Diarrhoea, Paraesthesia
Clinical narrative: Extreme back pain along spine; Excessive diarrhea, watery uncontrollable with cramping; Excessive diarrhea, watery uncontrollable with cramping; Tingling in both hands at time of injection; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 30Aug2021 at 14:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to adhesives, latex and non-steroidal anti-inflammatory drugs (NSAIDS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medication included daily probiotics (unspecified) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PA7484) via an unspecified route of administration in the left arm on 09Aug2021 at 14:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 30Aug2021 at 14:15, the patient experienced tingling in both hands at time of injection which lasted for 45 minutes. On 01Sep2021 at 08:00, the patient had extreme back pain along spine and the patient started to have excessive diarrhea, watery and uncontrollable with cramping, along with the other common side effects. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling in both hands at the time of injection was recovered on 30Aug2021 at 15:00. The clinical outcome of the events extreme back pain along spine and excessive diarrhea, watery uncontrollable with cramping was not recovered at the time of this report.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Headache, Pain in extremity
Clinical narrative: Dizzy- continued for over 3 weeks; Headache - off and on for weeks; Fatigue- over 3 weeks; Sore arm for few days; Diarrhea- day 3; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication from an unknown date and unknown if ongoing. On 10Aug2021, the patient was dizzy which continued for over 3 weeks. The patient also experienced headache which was off and on for weeks and had fatigue for over 3 weeks. The patient had sore arm for few days and experienced diarrhea-day 3. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy, headache, fatigue, sore arm and diarrhea were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Goitre, Lymphadenopathy
Clinical narrative: Swollen thyroid; Swollen thyroid and lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 11Aug2021 at 11:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date and unknown if ongoing. On 18Aug2021 at 12:00, the patient experienced swollen thyroid and lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen thyroid and lymph nodes were not resolved at the time of this report. The patient received second dose of BNT162b2 (COMIRNATY; Lot number: FC3183), via an unspecified route of administration in the left arm on 01Sep2021 at 11:15 (at the age of 34-years-old), as a single dose for COVID-19 immunisation.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue
Clinical narrative: Chills; Back ache; Tired; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Aug2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 01Sep2021, the patient experienced chills, back ache and tired. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, back ache and tired were recovered on an unknown date in Sep2021.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Dysmenorrhoea
Clinical narrative: Had cramps but no period; Had cramps but no period; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 19Aug2021 at 12:00 (at the age of 31-years old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient did not receive any concomitant medications. It was reported that the patient was about to start a new cycle the week of the first vaccination shot. On 20Aug2021, the patient experienced cramps but no period. The patient had reported this to multiple doctors and to obstetrician-gynaecologist (OB-GYN). This was not normal and the patient had never missed a period. The patient's last period was on 19Jul2021 and the normal cycle was usually between 28-30 days. The events resulted in doctors or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event cramps but no period was not resolved at the time of this report.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chills, Dyspnoea, Fatigue
Clinical narrative: Chest pressure; Shortness of breath; Tiredness/ tired; Headache; Muscle pain; Chills; Joint pain; Nausea; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 27Aug2021 at 09:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 06Aug2021 at 09:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 27Aug2021, first two days after second dose, the patient experienced chest pressure, shortness of breath, tiredness, headache, muscle pain, chills, joint pain, nausea, feeling unwell and tired. On 03Sep2021 at 01:00, the patient experienced all of the same symptoms on day 7,8 and 9 after the second dose and this was the problem. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pressure, shortness of breath, tiredness/tired, headache, muscle pain, chills, joint pain, nausea and feeling unwell were not resolved at the time of this report.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Nausea
Clinical narrative: Chest pressure; Shortness of breath; Tiredness/ tired; Headache; Muscle pain; Chills; Joint pain; Nausea; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 27Aug2021 at 09:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 06Aug2021 at 09:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 27Aug2021, first two days after second dose, the patient experienced chest pressure, shortness of breath, tiredness, headache, muscle pain, chills, joint pain, nausea, feeling unwell and tired. On 03Sep2021 at 01:00, the patient experienced all of the same symptoms on day 7,8 and 9 after the second dose and this was the problem. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pressure, shortness of breath, tiredness/tired, headache, muscle pain, chills, joint pain, nausea and feeling unwell were not resolved at the time of this report.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash, Swelling face
Clinical narrative: Very bad rashes on body; Swelling face; Allergy; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy just to peaches and peanut butter. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 01Aug2021 the patient experienced allergy, very bad rashes on body and swelling face. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and included treatment with unspecified antisthaminic. The clinical outcomes of the events allergy, very bad rashes on body and swelling face were unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Tinnitus
Clinical narrative: Neck ache - immediately; Humming in ears - immediately; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 01Sep2021 at 16:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (treated). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VIT C), zinc (MANUFACTURER UNKNOWN), colecalciferol (VIT D3) and hydrochlorothiazide/irbesartan (IRBESARTAN HCTZ); all for unknown indications from an unknown date and unknown if ongoing. On 01Sep2021 at 16:00, immediately after vaccination, the patient experienced neck ache and humming in ears. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events neck ache and humming in ears immediately was not recovered at the time of this report.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenitis, Lymphadenopathy
Clinical narrative: Lymphadenitis to axilla same side as injection, which has spread to  jaw, neck, chest, abdomen, and legs.; Lymph nodes are tender and enlarged; Lymph nodes are tender and enlarged; This is a spontaneous report from a contactable nurse, the patient. A 35-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 31Aug2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, rosacea, lymphedema, lipedema, allergy to gluten and soy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included doxycycline (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO), boswellia serrata (BOSWELLIA), curcuma longa (TURMERIC) and zingiber officinale (GINGER); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received minocycline (MANUFACTURER UNKNOWN) and experienced drug allergy. On 01Sep2021 at 07:00, the patient experienced lymphadenitis to axilla same side as injection, which had spread to the jaw, neck, chest, abdomen, and legs. The patient's lymph nodes were tender and enlarged but had no other complication. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lymphadenitis to axilla same side as injection, which has spread to the jaw, neck, chest, abdomen, legs, lymph nodes are tender and enlarged were resolving at the time of report.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Nausea, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 28, via an unspecified route of administration, on Aug 14, 2021, single dose, for COVID-19 immunisation. The patient did not have any medical history. The patient has no known allergies. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 28, via an unspecified route of administration, on Jul 24, 2021, single dose, for COVID-19 immunisation. On an unknown date in 2021 (after the second shot), patient felt nauseous and lightheaded. He also had hand numbness for just under a month. Reportedly, patient was just hoping for advice on what to do since it seemed to come in waves. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On Sep 5, 2021, patient underwent nasal swab COVID-19 test with negative result. No therapeutic measures taken as a result of the events. The outcome of felt nauseous, lightheaded and hand numbness: not recovered at the time of this report.